Association between fentanyl use and virologic suppression in an HIV-infected cohort of people who use/inject drugs (PWID): results from a bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) switch study

被引：0
|
作者：
Conway, B. [1 ,2 ]
Yi, S. [1 ]
Sharma, S. [1 ]
Yung, R. [1 ]
Truong, D. [1 ]
机构：
[1] Vancouver Infect Dis Ctr, Vancouver, BC, Canada
[2] Simon Fraser Univ, Burnaby, BC, Canada
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2022年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P127
引用
收藏
页码：121 / 122
页数：2
相关论文
共 43 条
  • [21] Starting or switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in clinical practice: pooled 12-month (12M) results from the global BICSTaR study
    Spinner, Christoph
    Stoehr, Albrecht
    Wong, Alexander
    de Wet, Joss
    Zeggagh, Jeremy
    Hocqueloux, Laurent
    van Welzen, Berend
    Heinzkill, Marion
    Sahali, Sabrinel
    Cornejo, Almudena Torres
    Ramroth, Heribert
    Haubrich, Richard
    Thorpe, David
    Kim, Connie
    INFECTION, 2021, 49 (SUPPL 1) : S16 - S16
  • [22] Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) for the treatment of people living with HIV: 24-month (24M) analyses by age, race, sex, adherence and late presentation in a multi-country cohort study
    Trottier, B.
    Antinori, A.
    De Wet, J.
    Duvivier, C.
    Elinav, H.
    Esser, S.
    Ghosn, J.
    den Hollander, J.
    Lambert, J.
    Milinkovic, A.
    Elliott, C.
    Saifi, T.
    Haubrich, R.
    Thorpe, D.
    Marongiu, A.
    Miralles, C.
    Schellberg, S.
    van Welzen, B.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 69 - 70
  • [23] Association between drug use and ART use among people living with HIV who inject drugs in Vietnam, Ukraine and Indonesia: results from HPTN 074
    Ha, Tran Viet
    Hoffman, Irving F.
    Miller, William C.
    Mollan, Katie R.
    Lancaster, Kathryn E.
    Richardson, Paul
    Zeziulin, Oleksandr
    Djoerban, Zubairi
    Sripaipan, Teerada
    Chu, Viet Anh
    Guo, Xu
    Hanscom, Brett
    Go, Vivian F.
    JOURNAL OF SUBSTANCE USE, 2022, 27 (06) : 648 - 657
  • [24] Four-year outcomes from the BICSTaR study: observational analysis of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naive (TN) and treatment-experienced (TE) people with HIV in Canada, France and Germany
    Wong, Alex
    Beer, Daniel
    Duvivier, Claudine
    Cordel, Hugues
    Meurer, Anja
    Thorpe, David
    Heinzkill, Marion
    Marongiu, Andrea
    Ramroth, Johanna
    Trottier, Benoit
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 73 - 74
  • [25] Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs
    Fogel, Jessica M.
    Zhang, Yinfeng
    Palumbo, Philip J.
    Guo, Xu
    Clarke, William
    Breaud, Autumn
    Richardson, Paul
    Piwowar-Manning, Estelle
    Hamilton, Erica L.
    Tran Viet Ha
    Dumchev, Kostyantyn
    Djoerban, Zubairi
    Hoffman, Irving
    Hanscom, Brett
    Miller, William C.
    Eshleman, Susan H.
    AIDS AND BEHAVIOR, 2019, 23 (08) : 2101 - 2108
  • [26] Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs
    Jessica M. Fogel
    Yinfeng Zhang
    Philip J. Palumbo
    Xu Guo
    William Clarke
    Autumn Breaud
    Paul Richardson
    Estelle Piwowar-Manning
    Erica L. Hamilton
    Tran Viet Ha
    Kostyantyn Dumchev
    Zubairi Djoerban
    Irving Hoffman
    Brett Hanscom
    William C. Miller
    Susan H. Eshleman
    AIDS and Behavior, 2019, 23 : 2101 - 2108
  • [27] Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study
    Friedman, Joseph R.
    Abramovitz, Daniela
    Skaathun, Britt
    Rangel, Gudelia
    Harvey-Vera, Alicia
    Vera, Carlos F.
    Artamonova, Irina
    Munoz, Sheryl
    Martin, Natasha K.
    Eger, William H.
    Bailey, Katie
    Go, Bo-Shan
    Bourgois, Philippe
    Strathdee, Steffanie A.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (04) : 1109 - 1116
  • [28] Effectiveness, persistence and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF), F/TAF+3rd agent or rilpivirine/F/TAF (R/F/TAF) in treatment-naive HIV-1 infected patients-24-month results from the German TAFNES cohort study
    Pauli, R.
    Jessen, H.
    Postel, N.
    Heuchel, T.
    Rieke, A.
    Hillenbrand, H.
    Kuemmerle, T.
    Schreiber, S.
    Goerner, K.
    Heinzkill, M.
    Haubrich, R.
    Stellbrink, H-J
    HIV MEDICINE, 2019, 20 : 54 - 55
  • [29] 24-Month (24M) effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naive (TN) and treatment-experienced (TE) people living with HIV in the BICSTaR study
    Garcia-Deltoro, Miguel
    Waizmann, Michael
    Robineau, Olivier
    Wong, Alexander
    Shahar, Eduardo
    Lambert, John S.
    van Welzen, Berend
    Boffito, Marta
    Yokomaku, Yoshiyuki
    Cassidy, Tali
    Marongiu, Andrea
    Thorpe, David
    Heinzkill, Marion
    Lluis-Ganella, Carla
    Di Perri, Giovanni
    HIV MEDICINE, 2023, 24 : 23 - 23
  • [30] Associated factors for progression to AIDS among HIV-infected people who use drugs: a retrospective cohort study in Dongguan, China
    Luo, Hao
    Sun, Mingwei
    Du, Jinlin
    BMJ OPEN, 2019, 9 (07):
12345